NO20075323L - Ernaeringspreparat for HIV-pasienter - Google Patents

Ernaeringspreparat for HIV-pasienter

Info

Publication number
NO20075323L
NO20075323L NO20075323A NO20075323A NO20075323L NO 20075323 L NO20075323 L NO 20075323L NO 20075323 A NO20075323 A NO 20075323A NO 20075323 A NO20075323 A NO 20075323A NO 20075323 L NO20075323 L NO 20075323L
Authority
NO
Norway
Prior art keywords
hiv patients
nutritional preparation
nutritional
preparation
hiv
Prior art date
Application number
NO20075323A
Other languages
English (en)
Norwegian (no)
Inventor
Eric Alexander Franciscus Tol
Johan Garssen
Johannes Wilhelmus Chri Sijben
George Veerlaan
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34939443&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20075323(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia Nv filed Critical Nutricia Nv
Publication of NO20075323L publication Critical patent/NO20075323L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
NO20075323A 2005-04-21 2007-10-17 Ernaeringspreparat for HIV-pasienter NO20075323L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67334205P 2005-04-21 2005-04-21
EP05103260A EP1721611A1 (en) 2005-04-21 2005-04-21 Nutritional supplement with oligosaccharides for a category of HIV patients
PCT/NL2006/050092 WO2006112717A2 (en) 2005-04-21 2006-04-19 Nutritional supplement for a category of hiv patients

Publications (1)

Publication Number Publication Date
NO20075323L true NO20075323L (no) 2008-01-21

Family

ID=34939443

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20075323A NO20075323L (no) 2005-04-21 2007-10-17 Ernaeringspreparat for HIV-pasienter

Country Status (14)

Country Link
US (1) US20090082249A1 (xx)
EP (2) EP1721611A1 (xx)
JP (1) JP2008536915A (xx)
CN (1) CN101262783A (xx)
AR (1) AR054256A1 (xx)
AU (1) AU2006237739A1 (xx)
BR (1) BRPI0610784A2 (xx)
CA (1) CA2605210A1 (xx)
MX (1) MX2007013082A (xx)
NO (1) NO20075323L (xx)
NZ (1) NZ562666A (xx)
RU (1) RU2007143060A (xx)
WO (1) WO2006112717A2 (xx)
ZA (1) ZA200709047B (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
WO2004019699A1 (en) * 2002-08-30 2004-03-11 Campina B.V. Foaming ingredient and products containing the ingredient
EP1597978A1 (en) * 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
RU2429718C2 (ru) * 2004-06-22 2011-09-27 Н.В. Нютрисиа Повышение целостности барьера у больных с вич
EP1723951A1 (en) * 2005-04-21 2006-11-22 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
US20080171720A1 (en) * 2005-04-21 2008-07-17 N.V. Nutricia Nutritional Supplement For Hiv Patients
WO2008156354A1 (en) * 2007-06-21 2008-12-24 N.V. Nutricia Modulation of intestinal flora of hiv patients
WO2009096772A1 (en) * 2008-02-01 2009-08-06 N.V. Nutricia Composition for stimulating natural killer cell activity
SG191799A1 (en) 2010-12-31 2013-08-30 Abbott Lab Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated polyunsaturated fatty acids and uses thereof
US8802650B2 (en) 2010-12-31 2014-08-12 Abbott Laboratories Methods of using human milk oligosaccharides for improving airway respiratory health
US9795623B2 (en) 2010-12-31 2017-10-24 Abbott Laboratories Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin C and anti-inflammatory agents
SG10202110501RA (en) 2010-12-31 2021-11-29 Abbott Lab Methods For Decreasing The Incidence Of Necrotizing Enterocolitis In Infants, Toddlers, Or Children Using Human Milk Oligosaccharides
BR112013015951A2 (pt) 2010-12-31 2018-07-10 Abbott Lab composições nutricionais compreendendo oligossacarídeos e nucleotídeos de leite humano e usos destas para tratar e/ou prevenir infecção viral entérica.
SG191393A1 (en) 2010-12-31 2013-08-30 Abbott Lab Neutral human milk oligosaccharides to promote growth of beneficial bacteria
MY165628A (en) 2010-12-31 2018-04-18 Abbott Lab Human milk oligosaccharides for modulating inflammation
WO2012177118A1 (en) * 2011-06-22 2012-12-27 N.V. Nutricia Method for reducing the occurrence of infection in young children
CN107595860A (zh) 2011-07-22 2018-01-19 雅培制药有限公司 用于预防胃肠道损伤和/或促进胃肠道修复的低聚半乳糖
SG2014013478A (en) 2011-08-29 2014-05-29 Abbott Lab Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
WO2015148384A1 (en) 2014-03-26 2015-10-01 Abbott Laboratories Nutritional supplement powder
WO2017151540A1 (en) 2016-02-29 2017-09-08 Abbott Laboratories Nutritional supplement powder

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2981629A (en) * 1960-04-05 1961-04-25 Lewis F Ginnette Process of dehydrating foams
US4237118A (en) * 1972-03-06 1980-12-02 Howard Alan N Dietary supplement and dietary methods employing said supplement for the treatment of obesity
JPS5645951B2 (xx) * 1973-05-21 1981-10-29
FR2490496A1 (fr) * 1980-09-19 1982-03-26 Roussel Uclaf Nouvelles glycoproteines immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
US4438147A (en) * 1982-06-25 1984-03-20 Societe D'assistance Technique Pour Produits Nestle S.A. Foaming creamer and method of making same
DE3734962C1 (de) * 1987-10-15 1989-01-05 Luitpold Werk Chem Pharm Verwendung von Chondroitinpolysulfat zur vorbeugenden,lindernden oder heilenden Behandlung von AIDS und ARC
JPH01149730A (ja) * 1987-12-07 1989-06-12 Osaka Prefecture レトロウイルス増殖抑制剤
DE68904264T2 (de) * 1988-08-24 1993-05-27 Akzo Nv Fragmente und fraktionen von heparin mit wirkung gegen hiv.
JP2782443B2 (ja) * 1988-12-26 1998-07-30 將純 吉原 抗エイズウィルス剤
ES2033193B1 (es) * 1990-10-30 1994-01-16 Ganadera Union Ind Agro Mezcla grasa para nutricion infantil y de adultos.
ZA92452B (en) * 1991-01-24 1992-10-28 Martek Corp Microbial oil mixtures and uses thereof
FR2673812B1 (fr) * 1991-03-13 1994-04-01 Roussel Uclaf Nouvelles compositions destinees a etre utilisees en dietetique et en therapeutique et renfermant une combinaison particuliere de glucides et leurs applications.
JPH04300888A (ja) * 1991-03-28 1992-10-23 Dainippon Ink & Chem Inc カルボン酸オリゴ糖エステル硫酸化物
IT1248060B (it) * 1991-06-14 1995-01-05 Italfarmaco Spa Eparine acilate come inibitori della replicazione di retrovirus
US5629023A (en) * 1991-12-31 1997-05-13 Bland; Jeffrey S. Medical food composition for metabolic detoxification
US5502041A (en) * 1992-12-11 1996-03-26 The Center For Innovative Technology Potent inhibitor of HIV reverse transcriptase
US5472952A (en) * 1993-03-18 1995-12-05 Bristol-Myers Squibb Company Partially hydrolyzed pectin in nutritional compositions
JP3310738B2 (ja) * 1993-11-10 2002-08-05 株式会社ロッテ 低カロリーチョコレート
DE4404877C1 (de) * 1994-02-17 1995-03-02 Ksk Industrielackierungen Gmbh Lackierverfahren und zur Durchführung des Verfahrens geeignete Lackgießvorrichtung
US5444054A (en) * 1994-04-01 1995-08-22 Abbott Labatories Method of treating ulcerative colitis
US5952314A (en) * 1994-04-01 1999-09-14 Demichele; Stephen Joseph Nutritional product for a person having ulcerative colitis
US5531989A (en) * 1994-10-28 1996-07-02 Metagenics, Inc. Immunoglobulin and fiber-containing composition for human gastrointestinal health
US5531988A (en) * 1994-10-28 1996-07-02 Metagenics, Inc. Bacteria and immunoglobulin-containing composition for human gastrointestinal health
JPH08151328A (ja) * 1994-11-28 1996-06-11 Fuji Ratetsukusu Kk エイズ感染防止潤滑剤
US5733579A (en) * 1995-04-05 1998-03-31 Abbott Laboratories Oral rehydration solution containing indigestible oligosaccharides
US20020016289A1 (en) * 1995-06-01 2002-02-07 Orla M. Conneely Methods for treatment and prevention of helicobacter pylori infection using lactoferrin
US5827526A (en) * 1995-07-11 1998-10-27 Abbott Laboratories Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans
DE69506095T2 (de) * 1995-08-04 1999-06-24 Nutricia Nv Diätfasern enthaltende Nahrungszusammensetzung
MY115050A (en) * 1995-10-16 2003-03-31 Mead Johnson Nutrition Co Diabetic nutritional product having controlled absorption of carbohydrate
JPH10108647A (ja) * 1996-10-08 1998-04-28 Meiji Seika Kaisha Ltd 胃切除術後患者用ミネラル補給材
JP4008974B2 (ja) * 1996-12-12 2007-11-14 森永乳業株式会社 ビフィズス菌増殖促進組成物及びその用途
DE19701382A1 (de) * 1997-01-16 1998-07-23 Nutricia Nv Kohlenhydratmischung
ATE265207T1 (de) * 1997-02-21 2004-05-15 Abbott Lab Verwendung von mehrfach ungesättigten fettsäuren zur vorbeugung von nekrotizierender enterokolitis
US5840361A (en) * 1997-04-09 1998-11-24 Beech-Nut Nutrition Corporation Fructan-containing baby food compositions and methods therefor
NL1005809C2 (nl) * 1997-04-14 1998-10-19 Dsm Nv Poederverfbindmiddelsamenstelling.
US5846569A (en) * 1997-06-20 1998-12-08 Creative Labs, Inc. Colostrum supplement
US6051260A (en) * 1998-04-07 2000-04-18 Healthcomm International, Inc. Medical food composition of reduced allergenicity, especially adapted for improving gut mucosal integrity
FR2781673B1 (fr) * 1998-07-28 2001-09-28 Univ Picardie Utilisation d'un glucuronane en tant qu'agent immunostimulant, procede de preparation
DE19836339B4 (de) * 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
US6231889B1 (en) * 1998-09-21 2001-05-15 Chronorx, Llc Unit dosage forms for the treatment of herpes simplex
US6794495B1 (en) * 1998-10-19 2004-09-21 New Nordic Danmark Aps Composition comprising extensin and, optionally, pectic polysaccharides
AU765510B2 (en) * 1999-01-28 2003-09-18 Societe Des Produits Nestle S.A. Aromatised soluble creamer powder
EP1074181A1 (en) * 1999-08-03 2001-02-07 Societe Des Produits Nestle S.A. Foaming creamer ingredient and powders containing it
DE19940011B4 (de) * 1999-08-24 2009-04-02 Schütte/Reichel GbR (vertretungsberechtigte Gesellschafter: Irene Schütte Alginataufbereitung und deren Verwendung
US6737089B2 (en) * 1999-08-27 2004-05-18 Morinda, Inc. Morinda citrifolia (Noni) enhanced animal food product
DE10006989A1 (de) * 2000-02-16 2001-08-23 Nutricia Nv Antiadhäsive Kohlenhydratmischung
US6846501B2 (en) * 2000-04-12 2005-01-25 Mid-America Commercialization Corporation Traditional snacks having balanced nutritional profiles
DE10027050A1 (de) * 2000-06-02 2001-12-13 Karim Balan Alginathaltige Zusammensetzung und deren Verwendung
US6426110B1 (en) * 2000-08-11 2002-07-30 Global Health Sciences, Inc. Low-carbohydrate high-protein creamer powder
US6592863B2 (en) * 2000-08-22 2003-07-15 Nestec S.A. Nutritional composition
CN1111541C (zh) * 2000-09-15 2003-06-18 青岛海洋大学 一种聚甘露糖醛酸硫酸盐
DE10057976B4 (de) * 2000-11-22 2005-02-03 Südzucker AG Mannheim/Ochsenfurt Verfahren zur Herstellung von Pektinhydrolyseprodukten
US6511696B2 (en) * 2000-12-13 2003-01-28 Novartis Nutrition Ag Infant formula with free amino acids and nucleotides
WO2002064714A1 (fr) * 2001-02-15 2002-08-22 Asahi Denka Kogyo Kabushiki Kaisha Produits contenant du $g(b)-glucane
AU2003245252A1 (en) * 2002-04-30 2003-11-17 Fmc Corporation Carrageenan based antimicrobial compositions
WO2004019699A1 (en) * 2002-08-30 2004-03-11 Campina B.V. Foaming ingredient and products containing the ingredient
US20040122105A1 (en) * 2002-09-20 2004-06-24 Griscom Bettle Transdermal compositions
US6974841B1 (en) * 2002-09-27 2005-12-13 Rapisarda Family Irrevocable Trust Pet anti-aging wellness supplement
US20040219188A1 (en) * 2003-05-02 2004-11-04 Comer Gail M. Composition and methods for nutritional management of patients with hepatic disease
AU2003904192A0 (en) * 2003-08-11 2003-08-21 Adelaide Research and Innovaiton Pty Ltd Method for inhibiting bacterial colonisation
RU2388478C2 (ru) * 2003-10-24 2010-05-10 Н.В. Нютрисиа Иммуномодулирующие олигосахариды
FR2866203B1 (fr) * 2004-02-13 2006-12-08 Roquette Freres Procede de fabrication d'un produit de cuisson a base de gluten
EP1597978A1 (en) * 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
US8252769B2 (en) * 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
EP1723951A1 (en) * 2005-04-21 2006-11-22 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
RU2429718C2 (ru) * 2004-06-22 2011-09-27 Н.В. Нютрисиа Повышение целостности барьера у больных с вич
EP1778857A4 (en) * 2004-07-07 2007-09-26 Gen Hospital Corp DIRECT ACTIVATION OF ATIII IN FULL BLOOD AND PLASMA
EP1919300A1 (en) * 2005-07-27 2008-05-14 Cantabria Group LCC Phosphorytated glucomannan polysaccharides containing 1-6 and 1-2 linkages increase weight gain in swine

Also Published As

Publication number Publication date
US20090082249A1 (en) 2009-03-26
MX2007013082A (es) 2008-01-11
WO2006112717A2 (en) 2006-10-26
CA2605210A1 (en) 2006-10-26
EP1721611A1 (en) 2006-11-15
RU2007143060A (ru) 2009-06-10
JP2008536915A (ja) 2008-09-11
NZ562666A (en) 2011-03-31
ZA200709047B (en) 2008-09-25
WO2006112717A3 (en) 2007-07-12
BRPI0610784A2 (pt) 2010-11-09
CN101262783A (zh) 2008-09-10
AU2006237739A1 (en) 2006-10-26
EP1874136A2 (en) 2008-01-09
AR054256A1 (es) 2007-06-13

Similar Documents

Publication Publication Date Title
NO20075323L (no) Ernaeringspreparat for HIV-pasienter
PT2222669E (pt) Derivados de oxadiazole ativos em esfingosina-1-fosfato (s1p)
MY148108A (en) Medicaments for the treatment or prevention of fibrotic diseases
EP1521749B8 (en) PHENYL-(4-(3-PHENYL-1H-PYRAZOL-4-YL)-PYRIMIDIN-2-Yl)-AMINE DERIVATIVES
SE0001899D0 (sv) New compounds
NO20042596L (no) Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1
WO2009002867A3 (en) Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
ATE410424T1 (de) Spirocyclische cyclohexan-derivate
MX2010006204A (es) Derivados de oxindol 5,6-disubstituidos y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina.
TW200740429A (en) Methods and dosage forms for reducing side effects of carbamate compounds
NO20081942L (no) Karbamoylbenzotriazolderivater som inhibitorer av lipaser og fosfolipaser
SI1680128T1 (sl) Mio-inozitol heksafosfat za topično uporabo
NO20084826L (no) Ny administrasjonsform av racecadotril
MX2009013501A (es) Compuestos piperidinicos y sus usos.
NO20082047L (no) Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme
TN2009000275A1 (en) Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome
TW200801032A (en) Azaheterocyclyl derivatives of androstanes and androstenes as medicaments for cardiovascular disorders
ECSP045493A (es) Nuevas composiciones farmacéuticas que contienen flibanserina polimorfo a
AU2020278236A8 (en) Methods of treating Sjögren's Syndrome using a Bruton's tyrosine kinase inhibitor
NO20092763L (no) Isosorbid mononitrat derivater for behandling av tarmlidelser
PL1994926T3 (pl) Preparaty walsartanu
BRPI0516545A (pt) uso de óleo de lavanda para a profilaxia e tratamento de neurastenia, distúrbios de somatização e outras doenças associadas ao estresse
GEP20125709B (en) Chromane derivatives as trpv3 modulators
ES2325291A1 (es) "uso de un extracto de silybum marianum"
DE602007004348D1 (de) Arzneimittel zur behandlung von sarkoglykanopathien

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application